KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Teladoc Health (TDOC) Revenue (2016 - 2025)

Historic Revenue for Teladoc Health (TDOC) over the last 12 years, with Q3 2025 value amounting to $626.4 million.

  • Teladoc Health's Revenue fell 219.65% to $626.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.5 billion, marking a year-over-year decrease of 237.14%. This contributed to the annual value of $2.6 billion for FY2024, which is 126.19% down from last year.
  • Teladoc Health's Revenue amounted to $626.4 million in Q3 2025, which was down 219.65% from $631.9 million recorded in Q2 2025.
  • Over the past 5 years, Teladoc Health's Revenue peaked at $660.5 million during Q4 2023, and registered a low of $453.7 million during Q1 2021.
  • For the 5-year period, Teladoc Health's Revenue averaged around $605.2 million, with its median value being $629.4 million (2025).
  • In the last 5 years, Teladoc Health's Revenue skyrocketed by 15092.78% in 2021 and then crashed by 303.33% in 2024.
  • Quarter analysis of 5 years shows Teladoc Health's Revenue stood at $554.2 million in 2021, then increased by 15.06% to $637.7 million in 2022, then rose by 3.58% to $660.5 million in 2023, then fell by 3.03% to $640.5 million in 2024, then fell by 2.19% to $626.4 million in 2025.
  • Its last three reported values are $626.4 million in Q3 2025, $631.9 million for Q2 2025, and $629.4 million during Q1 2025.